Nostopharma
Bethesda
About Nostopharma
Nostopharma provides pathologic bone growth treatment intended to prevent rare bone disease. Their treatment assists patients in forming new bone following surgeries, burns, injuries, and other traumas, enabling healthcare providers to cure their patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.0M
- Last round: Series Unknown (Jan 2025)
- Website: nostopharma.com
- Phone: 240-997-5073
Industries & Categories
Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/nostopharma-57379 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.